UTI Pathogens
Rapid Detection of Urinary Tract Pathogens
HealthTrackRx (HTRx) is the premier specialty diagnostic laboratory dedicated to the detection of infectious diseases.
With a decades-long track record of industry-leading technological advancement, our assays deliver accurate, actionable data with best-in-class turnaround time.
99% of samples received by our lab are reported out within 24-36 hours of receipt.
Eliminate the Guesswork in Diagnosis and Treatment
Our UTI pathogen assay utilizes the latest in quantitative RT-PCR technology to rapidly and reliably analyze your patient’s sample.
We rapidly detect and differentiate 99% of the most relevant bacterial, viral, and fungal targets, eliminating the need for costly, inaccurate, and time-consuming follow up testing.
Our molecular technique provides a more definitive diagnosis than POC antigen assays*
Our UTI Diagnostics:
- Reduce false negatives
- Detect polymicrobial infections
- Are unaffected by concurrent antibiotic use
- Include one of the most extensive antibiotic resistance gene menus
- Reduce unnecessary drug exposure and adverse events
- Report within 24-36 hours of sample receipt
Prescribe with Confidence
As the leader in testing sensitivity and specificity, our reports include a custom-designed accurate and detailed antibiogram.
- Support antibiotic stewardship by reducing over-utilization of broad-spectrum anti-infectives
- Decrease the need for empiric therapy
- Reduce unnecessary drug exposure, adverse events, cost of repeat testing, and multiple treatment attempts
The New 99%
Over 99% of results are reported within 24-36 hours of sample receipt
Over 99% sensitivity to reduce false negatives
Over 99% specificity to reduce false positives
Over 99% of the most common pathogens detected
100% trackable samples and results
Learn More
(940) 383-2223 | [email protected] | www.healthtrackrx.com
UTI Pathogens Profile
Acinetobacter baumanii
Candida albicans, glabrata, parapsilosis, tropicalis
Candida auris
Chlamydia trachomatis
Citrobacter freundii
Escherichia coli
Enterobacter aerogenes, cloacae
Enterococcus faecalis, faecium
Klebsiella pneumoniae, oxytoca
Morganella morganii
Mycoplasma genitalium, hominus
Neisseria gonorrhoeae
Proteus mirabilis, vulgaris
Pseudomonas aeruginosa
Serratia marcescens
Staphylcoccus aureus
Staphylococcus (coagulase negative: epidermidis, haemolyticus, lugdunensis, saprophyticus)
Streptococcus agalactiae (Group B strep (GBS))
Streptococcus pyogenes (Group A strep)
Trichomonas vaginalis
Ureaplasma urealyticum, parvum
Antibiotic Resistance
VanA, VanB (Vancomycin resistance)
ermB, C; mefA (Macrolide Lincosamide Streptogramin)
SHV, KPC Groups (Class A beta lactamase)
dfr (A1, A5), sul (1, 2) probes (Trimethoprim/Sulfamethoxazole resistance)
mecA (Methicillin gene)
qnrA1, qnrA2, qnrB2 (Fluoroquinolone genes)
tet B, tet M (Tetracycline genes)
IMP, NDM, VIM Groups (Class B metallo beta lactamase)
ACT, MIR, FOX, ACC Groups (AmpC beta lactamase)
OXA-48,-51 (Class D oxacillinase)
CTX-M1 (15), M2 (2), M9 (9), M8/25 Groups (Class A beta lactamase)
Effective 7/13/2020
*Van der Zee A, Roorda L, Bosman G, Ossewaarde JM (2016) Molecular Diagnosis of Urinary Tract Infections by Semi-Quantitative Detection of Uropathogens in a Routine Clinical Hospital Setting. PLoS ONE 11(3): e0150755. Doi:10.1371/journal.pone.0150755
Learn More
Ready to improve outcomes with fast, accurate diagnostic results? Contact us to learn more.
Click below to schedule your consultation.